ASX 200 healthcare share sinks on $2 billion asset sale

Investors are pressuring the healthcare share amid news of a major hospital sale.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is slipping today.

The healthcare stock closed on Friday trading for $53.93 a share. In early trade on Monday, shares are swapping hands for $53.35, down 1.08%.

For some context, the ASX 200 is down 0.19% at this same time.

This comes following news of a multi-billion-dollar hospital asset sale.

Shot of a mature scientists working on a laptop in a lab.

Image source: Getty Images

What did the ASX 200 healthcare share announce?

ASX 200 investors are pressuring the healthcare share after the company reported it has reached an agreement – together with its partner Sime Darby Holdings Berhad – to sell its 50:50 joint venture in Asia, Ramsay Sime Darby Health Care.

Columbia Asia Healthcare will pay MYR6.06 billion (approximately AU$2 billion) for hospital assets, representing 100% of the joint venture's enterprise value.

Ramsay said it expects to achieve a net profit after tax (NPAT) for its share of the joint venture of around $630 million. This will be reflected in the company's FY 2024 full-year results through the "discontinued operations line".

Management expects pre-tax (post-transaction cost) proceeds of around $935 million. The ASX 200 healthcare share will use the funds to pay down debt. This is expected to result in annualised interest cost savings of $55 million.

FY 2024 net interest costs (including AASB16 lease costs) are now expected to be at the lower end of Ramsay's previously guided range of $570 million to $600 million.

Commenting on the asset sale, Sime Darby CEO Jeffri Salim Davidson said, "While the hospital business is a great asset … the offer from Columbia Asia was one we could not refuse."

Subject to the receipt of regulatory approval from Australia's Foreign Investment Review Board, the sale is expected to be completed by the end of 3Q FY 2024.

Ramsay Health Care share price snapshot

Up 7% over the past month, the ASX 200 healthcare share remains down almost 13% over the past full year.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Up 1,173% in a year, what do 4DMedical shares have over other healthcare stocks?

Expert explains why 4DMedical is somewhat sheltered from today's sector headwinds.

Read more »

A couple sits on the bed in their hotel room wearing white robes, both have seen the bad news on their phones.
Earnings Results

What's going on with ResMed shares today?

The sleep disorder treatment company has released its third-quarter update this morning.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Healthcare Shares

Resmed reports double-digit revenue and profit increases in Q3 FY26

Resmed posted double-digit revenue and profit growth in Q3 FY26, with management confident about continued momentum.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares crashed in April, but is a comeback looming?

This ASX 200 healthcare stock is caught between short-term pain and long-term potential.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder, as if giving comfort.
Healthcare Shares

What's making healthcare the worst sector on the ASX 200, down 39% in a year?

An expert outlines the key headwinds weighing on the industry and share prices today.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Good news, falling shares: What's dragging this ASX stock lower?

In biotech, strong updates don't always push the share price higher.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

Mesoblast shares: Cash burn falls and Ryoncil® sales climb

Mesoblast reports higher Ryoncil® sales, improved cash management, and research milestones for the March 2026 quarter.

Read more »